-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓ISIN US00650F1093-
Adaptive BiotechnologiesBörse Xetra FrankfurtEURSymbol 1HM
-
Adaptive BiotechnologiesBörse Börse BerlinEURSymbol 1HM
-
Adaptive BiotechnologiesBörse Börse MünchenEURSymbol 1HM
-
ADAPTIVE BIOTECHNOLOGIESBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 1HM
-
ADAPTIVE BIOTECHNOLOGIESBörse Börse DüsseldorfEURSymbol 1HM
-
ADAPTIVE BIOTECHNOLOGIESBörse Gettex System der Börse MünchenEURSymbol 1HM
-
ADAPTIVE BIOTECHNOLOGIESBörse Börse StuttgartEURSymbol 1HM
-
ISIN US00650F1093 WKN: A2PLR5Symbol ADPT
-
EURSymbol 1HM
-
ISIN US00650F1093
WKN A2PLR5
Symbol ADPT
Firmenname
Adaptive Biotechnologies Corporation
Marktkapitalisierung
6.886.168.992 (+- 32%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
9.095.337.984 oder 4.677.000.000
Mitarbeiter
656 (+- 31%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
453 oder 858 Mitarbeiter
KGV
43.96
EBITDA -52.744.000
Buchwert 5.682
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 33,4 EUR +1,21%
Portrait der Adaptive Biotechnologies Aktie
Das Unternehmen Adaptive Biotechnologies Corporation aus USA beschäftigt 656 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Das Unternehmen Adaptive Biotechnologies Corporation ist nur in 6 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Adaptive Biotechnologies mit 0,37% im ETF.
6 ETFs die in Adaptive Biotechnologies investieren
Dir gefallen die Informationen zu Adaptive Biotechnologies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Adaptive Biotechnologies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Adaptive Biotechnologies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Adaptive Biotechnologies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
32 News & Informationen zur Adaptive Biotechnologies Aktie
Cathie Wood’s ARK Invest Buys for 8
Here's a look at the ARK Invest Buys for August 27, 2021.
Cathie Wood’s ARK Invest Buys for 8
Here's a look at the ARK Invest Buys for August 25, 2021.
SB Management Ltd Buys Century Therapeutics Inc, Lyell Immunopharma Inc, ironSource, Sells Facebook Inc, Microsoft Corp, PayPal Holdings Inc
GuruFocus Article or News written by insider and the topic is about:
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
Adaptive Biotechnologies Corp (ADPT) CFO Chad M Cohen Sold $511,050 of Shares
GuruFocus Article or News written by insider and the topic is about:
Nasdaq finalizes new board diversity rules — and some companies may have some explaining to do
The Nasdaq stock exchange this month received approval for new rules that encourage companies to appoint more diverse boards of directors.
Cathie Wood’s ARK Invest Buys Over 940,000 Shares of This Augmented Reality Firm – 24
On August 10, a couple of Cathie Wood's ARK Invest funds bought over 940,000 shares of Vuzix, a biotech-focused special purpose acquisition company.
Curebase : Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access
SAN FRANCISCO and SEATTLE, Aug. 10, 2021 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. , a biotechnology company… | August 10, 2021
Andreas Halvorsen Gets a Healthy Dose of Rallybio
GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Guru invests in newly public biotech company
Cathie Wood’s ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC – 24/7 Wall St.
On August 9, a couple of Cathie Wood's ARK Invest funds bought over 7 million shares of Soaring Eagle Acquisition, a biotech-focused special purpose acquisition company.
Cathie Wood’s ARK Invest Buys for 8
Here's a look at the ARK Invest Buys for August 9, 2021.
Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q2 2021 Results – Earnings Call Transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2021 Earnings Conference Call August 4, 2021 16:30 ET Company Participants Karina Calzadilla – Vice President of Investor Relations…
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 18.60% and 20.16%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Adaptive Biotechnologies : Reports Second Quarter 2021 Financial Results (Form 8-K)
Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease,… | August 4, 2021
Adaptive Biotechnologies Appoints Nitin Sood As Chief Commercial Officer
SEATTLE, Aug. 04, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate
Adaptive Biotechnologies Q2 2021 Earnings Preview (NASDAQ:ADPT)
Adaptive Biotechnologies (NASDAQ:ADPT) is scheduled to announce Q2 earnings results on Wednesday, August 4th, after market close.The consensus EPS Estimate is -$0.41 (-57.7% Y/Y) and…
Close Asset Management Ltd Buys ChargePoint Holdings Inc, ChargePoint Holdings Inc, Illumina Inc, Sells Starbucks Corp, Ingredion Inc, Sony Group Corp
GuruFocus Article or News written by insider and the topic is about:
Inflation Concerns Ruin First Week of Earnings Season
Stocks Analysis by Zacks Investment Research covering: International Business Machines, Texas Instruments Incorporated, Netflix Inc, CBOE Volatility Index. Read Zacks Investment Research's latest article on Investing.com
Do Hedge Funds Love Rexnord Corp (RXN)?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact,…
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021
SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to…
Adaptive Biotechnologies Corp (ADPT) CFO Chad M Cohen Sold $773,600 of Shares
GuruFocus Article or News written by insider and the topic is about:
The push for corporate board diversity is growing. How do Pacific NW tech companies stack up?
Former drugstore.com CEO and board chair Dawn Lepore doesn’t need to be convinced that it's important to have diversity on company boards of directors.
This Explosive Biotech Is Taking On a Huge New Market
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.
Hedge Funds Are Buying Haemonetics Corporation (HAE)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge…
Hedge Funds Are Selling Eagle Materials, Inc. (EXP)
Is Eagle Materials, Inc. (NYSE:EXP) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question…
Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more
— Adaptive Biotechnologies co-founders and brothers Chad and Harlan Robins are among the directors of a new life sciences SPAC. The blank check company is…
GenomeWeb Index Drops 3% for 2nd Consecutive Month
GenomeWeb Index Drops 3% for 2nd Consecutive Month, Stocks: VIVO,GNMK,ADPT,BRN,QNTX,RHHBY, release date:Apr 13, 2021
Adaptive Biotechnologies Corp (ADPT) CEO and Chairman Chad M Robins Sold $627,150 of Shares
Adaptive Biotechnologies Corp (ADPT) CEO and Chairman Chad M Robins Sold $627,150 of Shares, Stocks: ADPT, release date:Apr 09, 2021
Stocks That Hit 52-Week Highs On Friday
This morning 150 companies reached new 52-week highs.
Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm by market cap to set a new …
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …
6 Stocks Added to Most Weighted Portfolio in 2021
6 Stocks Added to Most Weighted Portfolio in 2021, Stocks: ADPT,AER,BABA,DIS,PCG,TRN,GLRE, release date:Jan 06, 2021